Sunday, October 24, 2021
wellness India Expo
Home Tags Abbott

Tag: Abbott

Abbott to host first global Congress on medication adherence & behavioural...

From October 20th-21st, 2021, the organization is convening world-renowned experts across therapeutic areas to share their knowledge, experiences and insights about adherence

Abbott introduces room temp stable Carbetocin for Postpartum Haemorrhage in India

The novel, room-temperature-stable (RTS), single-dose formulation will address prevailing challenges with existing protocols that require cold-chain storage and transportation...................

Abbott launches new device for premature babies with heart defects in...

First and only minimally invasive, transcatheter treatment specifically approved for premature babies with patent ductus, a life-threatening opening in their heart (a common congenital defect).............................

Abbott researchers find rare group of people with controlled HIV who...

A study of more than 10,000 people identifies a rare group with controlled HIV in the Democratic Republic of Congo, suggesting additional research could uncover links between natural virus suppression and future treatments........................

Pan-India study shows young Indians aged 18-30 years are most affected...

A pan-India study underscores that 77% of the population tested showed deficiency and the prevalence is highest in adults aged 18-30 years (81.2%)....................

Abbott strengthens structural heart portfolio with new clip delivery system

Minimally invasive heart valve repair device for leaking mitral valve launched by the company brings this life-saving treatment to people in need, including those at high risk of surgery .............

Abbott launches next-generation heart rhythm management devices in India

New ICD (implantable cardioverter defibrillator) and CRT-D (cardiac resynchronization therapy defibrillator) family of devices offer patients and their doctors a smartphone app and Bluetooth® capability designed to help doctors tailor therapy to a patient’s unique clinical needs.....................

72% of patients globally & 56% Indian patients feel that data...

New research found physicians and patients agree that there are widening gaps in vascular disease treatment. 55% of physicians from nine countries around the globe, including India, say the shortage of time to spend with each patient is the biggest challenge to improving the patient experience and delivering better outcomes.................

Abbott & 1mg bring continuous glucose monitoring solutions closer to Indian...

Abbott’s professional flash glucose monitoring system will be made available online on 1mg for the first time in India. 1mg will provide an onsite phlebotomy* service at the patient’s home to help administer the sensor and take readings of the data after 14 days........................

COVID-19: Abbott begins supply of IgG based antibody tests to India

Abbott's SARS-CoV-2 IgG test can be used for large-scale antibody testing, in line with the ICMR recommendation for the use of IgG CLIA (Chemiluminescence immunoassay) tests. It has demonstrated reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days or more after symptoms started...................